Fresenius Medical Care Stock Steadies After JPMorgan Downgrade
Fresenius Medical Care AG's stock price has stabilized after JPMorgan downgraded its rating to Underweight on September 9, 2026. The company's share price had dipped 0.1 percent on Xetra on September 8, 2026, trading at EUR 38.44.
According to finanzen.net, the average analyst target for Fresenius Medical Care stood at EUR 42.02, which is about EUR 3.58 below the current stock price of EUR 38.44.
The company confirmed its 2026 earnings guidance and expects broadly flat revenue development, as reported by Simply Wall St on September 11, 2026.